Viewing Study NCT03702361


Ignite Creation Date: 2025-12-24 @ 12:17 PM
Ignite Modification Date: 2026-06-02 @ 10:18 PM
Study NCT ID: NCT03702361
Status: COMPLETED
Last Update Posted: 2021-03-19
First Post: 2018-08-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Rapid Intravenous Infusion of Velaglucerase Alfa (VPRIV) in Treatment-naive Patients With Type 1 Gaucher Disease
Sponsor: Shaare Zedek Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Primary Disease View
Keywords: